Conference abstract
Co-delivery of quercetin and paclitaxel drug via tri-block (PEO-PPO-PEO), PVP57-PVA30-PEG13 and di-block (PVP-PVA) copolymeric mixed micelles for drug resistant Breast Cancer
Manchester Metropolitan University, UK Guru Nanak Dev University, India DAV University, Jalandhar
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breast cancer is the second most common cancer worldwide after lung cancer and the fifth most common cause of cancer death in women. The worldwide weight of breast cancer surpasses every single other cancer and the frequency rates of cancer are expanding. In light of these grim statistics, we have developed novel PEO13- PPO45-PEO13 and PVP111-PVA86, PEO13-PPO45-PEO13 and PVP57-PVA30-PEG13 mixed micelles for the co-delivery of Quercetin (QCT) and Paclitaxel (PTX) for the treatment of Drug-resistant breast cancer. Pure and mixed nano-micelles were prepared using the direct dissolution method and characterized by fluorescence spectroscopy, dynamic light scattering (DLS) and scanning electron microscopy (SEM). UV-visible spectroscopy as well as the High performance liquid chromatography (HPLC) has been employed to screen the loading of anticancer drugs in different ratio of mixed micelles. We observed that loading of anticancer drugs in mixed micelles is higher than that of the pure polymeric micelles. The locus of solubilization of the anticancer drugs (QCT and PTX) in these polymeric micelles has been adjudged by 1H NMR spectroscopy. In-vitro drug release of the prepared formulations was performed using dialysis release methods. Cytotoxicity assay of prepared formulations was also performed on MCF-7 and triple negative breast cancer cell line MDAMB-231 to find out the anticancer activity. Furthermore, mixed micelles showed a significant increase on QCT and PTX cellular uptake in comparison with pure pluronic micelles and free drug in all cell lines assayed.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pankaj Singla”
- BylineArticles whose byline prints “Rakesh Kumar Mahajan”
- BylineArticles whose byline prints “Marloes Peeters”